Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSIGLITAZONE vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROSIGLITAZONE vs ROSUVASTATIN: Safety Overview

Metric ROSIGLITAZONE ROSUVASTATIN
Total FAERS Reports 45,976 36,332
Deaths Reported 4,661 1,536
Death Rate 10.1% 4.2%
Hospitalizations 23,675 11,195
Average Patient Age 60.2 yrs 66.1 yrs
% Female Patients 42.8% 54.9%
FDA Approval Date Jan 25, 2013 Apr 1, 2020
Manufacturer N/A Umedica Laboratories USA Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription